Anti-Aging Drugs: Where are We and Where are We Going?
Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons
Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development
Nanotechnology in Anti-Aging: Nutraceutical Delivery and Related Applications
Antioxidant Therapy of Aging: From Free Radical Chemistry to Systems Theory of Reliability
Mitochondria-Targeted Rechargeable Antioxidants as Potential Anti-Aging Drugs
Therapeutic Potential of Sirtuin Inhibitors in Cancer
Lifespan-Extending Effect of Resveratrol and Other Phytochemicals
Extending Lifespan by Inhibiting the Mechanistic Target of Rapamycin (mTOR)
Anti-Aging Action of PPARs: Potential Therapeutic Targets
S-Adenosylmethionine Metabolism: A Promising Avenue in Anti-Aging Medicine?
Short Peptides Regulate Gene Expression, Protein Synthesis and Enhance Life Span
Human Life Extension: Opportunities, Challenges, and Implications for Public Health Policy
About this book
Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by certain approaches. Substantial evidence has emerged supporting the possibility of radical human health and lifespan extension, in particular through pharmacological modulation of aging. A number of natural dietary ingredients and synthetic drugs have been assumed to have geroprotective potential. In the development of anti-aging therapeutics, several cell, insect, and animal models may provide useful starting points prior to human studies.
This book provides an overview of current research aimed to search for life-extending medications and describes pharmacological aspects of anti-aging medicine. Readers are introduced to the fascinating historical background of geroprotection in the first chapter. In-depth information on models for investigating geroprotective drugs precedes a section covering anti-aging properties of pharmaceutical compounds, such as calorie restriction mimetics, autophagy inducers, senolytics and mitochondrial antioxidants. Finally, strategies to translate discoveries from aging research into drugs and healthcare policy perspectives on anti-ageing medicine are provided to give a complete picture of the field.
A timely and carefully edited collection of chapters by leading researchers in the field, this book will be a fascinating and useful resource for pharmacologists, gerontologists and any scientifically interested person wishing to know more about the current status of research into anti-aging remedies, challenges and opportunities.
Alexander Vaiserman was born in KIev, Ukraine, in 1957. He earned his MSc Degree in cytology and developmental biology from Kiev State University in 1984, and his DSc degrees in normal physiology from Instiute of Gerontology (Kiev, Ukraine) in 1991 and 2004, respectively. Since 1978, he has had a permanent position in the Instiute of Gerontology (Kiev, Ukraine). Since 2010, he has been the head of the Laboratory of Epigenetics in the Instiute of Gerontology (Kiev, Ukraine). His research interests comprise epigenetics, epidemiology and experimental gerontology.